Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.45 |
| ▸ | PDE5A | O76074 | 2/20 | 0.43 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.43 |
| ▸ | GPR3 | P46089 | 1/20 | 0.41 |
| ▸ | NR1H2 | P55055 | 2/20 | 0.41 |
| ▸ | NR1H3 | Q13133 | 2/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | EGFR | P00533 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.40 |
| ▸ | RAB9A | P51151 | 2/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.40 |
| ▸ | DPP4 | P27487 | 1/20 | 0.40 |
| ▸ | CTRC | Q99895 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 3/20 | 0.39 |
| ▸ | POLB | P06746 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23686640 | 0.92 | GPR3 (0.48) | KDM4EGPR3ATMRAB9ACYP1A2 | |
| SCHEMBL15501884 | 0.92 | GPR3 (0.48) | KDM4EGPR3ATMRAB9ACYP1A2 | |
| SCHEMBL20561300 | 0.91 | GPR3 (0.41) | KDM4EGPR3ATMNPC1RAB9A | |
| SCHEMBL22025225 | 0.91 | PDE5A (0.43) | KDM4EPDE5AABCG2GPR3NR1H2 | |
| SCHEMBL19802291 | 0.91 | HTT (0.49) | KDM4EPDE5AABCG2NR1H2NR1H3 | |
| SCHEMBL25645941 | 0.91 | GPR3 (0.47) | KDM4EGPR3ATMRAB9ACYP1A2 | |
| SCHEMBL24808288 | 0.90 | GPR3 (0.40) | KDM4EGPR3ATMRAB9AHTT | |
| SCHEMBL18212422 | 0.89 | GPR3 (0.45) | KDM4EGPR3ATMRAB9AMAPK1 | |
| SCHEMBL22329662 | 0.88 | MAPT (0.45) | KDM4EGPR3ATMRAB9ACYP1A2 | |
| SCHEMBL25000309 | 0.88 | GPR3 (0.44) | KDM4EGPR3ATMRAB9ACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12167689-B2 | Heterocyclic compound and organic light emitting device comprising the same | LG CHEM, LTD. (KR) | 2024-12-10 | — | — | US | disclosed |
| US-11903311-B2 | Heterocyclic compound and organic light emitting device comprising the same | LG CHEM, LTD. (KR) | 2024-02-13 | — | — | US | disclosed |
| US-20220336757-A1 | NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2022-10-20 | — | — | US | disclosed |
| EP-3480194-B1 | HETEROCYCLIC COMPOUNDS AND ORGANIC LIGHT-EMITTING DEVICES USING SAME | LG CHEMICAL LTD (KR) | 2021-09-08 | — | — | EP | disclosed |
| EP-3480194-A1 | NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME | LG Chem, Ltd. (KR) | 2019-05-08 | — | — | EP | disclosed |
| US-20180337348-A1 | NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2018-11-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11903311-B2 | Heterocyclic compound and organic light emitting device comprising the same | CYP1A1, CYP1B1, CHRM1 | KDM4E 3276/4885PDE5A 4561/4885ABCG2 3127/4885 |
| US-20180337348-A1 | NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | CRY1, CRY2, ORC3 | KDM4E 2030/4885PDE5A 3972/4885ABCG2 2246/4885 |
| US-12167689-B2 | Heterocyclic compound and organic light emitting device comprising the same | C1S, ARRB1, CRY1 | KDM4E 3830/4885PDE5A 4562/4885ABCG2 3605/4885 |
| US-20220336757-A1 | NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | C1S, CNR1, ARRB1 | KDM4E 3734/4885PDE5A 4539/4885ABCG2 3218/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.